We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
(+8.9%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$127M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$126M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$122M |
| 4 |
SkinHealth Systems
SKIN
|
+$90.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$210M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$187M |
| 3 |
XYZ
Block Inc
XYZ
|
+$111M |
| 4 |
Danaher
DHR
|
+$109M |
| 5 |
Monster Beverage
MNST
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Financials | 16.56% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRHC
126
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $37M | 0.15% |
3,769,597
+1,919,015
| +104% | +$18.8M |
|
127
DoorDash
DASH
$75.3B
| $36.6M | 0.15% |
177,881
-125,690
| -41% | -$24M |
|
|
JWN
128
DELISTED
Nordstrom
JWN
| $36.4M | 0.15% |
+1,375,883
| New | +$43.9M |
|
129
Alcon
ALC
$33.1B
| $36.3M | 0.15% |
449,715
-237,611
| -35% | -$18.3M |
|
130
Leslie's
LESL
$11.6M
| $35.7M | 0.15% |
86,928
+36,758
| +73% | +$17.6M |
|
131
Eli Lilly
LLY
$1.07T
| $35.6M | 0.15% |
153,885
+59,571
| +63% | +$14.7M |
|
|
CONX
132
DELISTED
CONX Corp. Class A Common Stock
CONX
| $35.5M | 0.15% |
3,618,414
+1,818,442
| +101% | +$17.8M |
|
133
Zscaler
ZS
$23B
| $35M | 0.15% |
133,630
+109,731
| +459% | +$27.6M |
|
134
Royal Bank of Canada
RY
$291B
| $35M | 0.15% |
352,150
+31,674
| +10% | +$3.23M |
|
|
NBIS
135
Nebius Group N.V.
NBIS
$47.7B
| $35M | 0.15% |
438,889
-326,430
| -43% | -$23.8M |
|
136
BHP
BHP
$213B
| $34.7M | 0.14% |
727,303
+30,528
| +4% | +$1.86M |
|
|
AAC
137
DELISTED
Ares Acquisition Corporation
AAC
| $34.3M | 0.14% |
3,518,005
+2,218,535
| +171% | +$21.6M |
|
138
Okta
OKTA
$24.1B
| $34.3M | 0.14% |
144,327
+97,795
| +210% | +$24.3M |
|
|
NUAN
139
DELISTED
Nuance Communications, Inc.
NUAN
| $33.9M | 0.14% |
616,783
+401,745
| +187% | +$22.1M |
|
140
Qualcomm
QCOM
$176B
| $33.7M | 0.14% |
261,609
+124,195
| +90% | +$17.6M |
|
141
JD.com
JD
$40.8B
| $33.4M | 0.14% |
462,577
+359,214
| +348% | +$26.5M |
|
142
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
| $33.2M | 0.14% |
659,500
+75,800
| +13% | +$3.95M |
|
143
Teradyne
TER
$54.8B
| $33.2M | 0.14% |
304,256
+249,160
| +452% | +$30.3M |
|
144
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $32.9M | 0.14% |
485,400
-184,200
| -28% | -$11.8M |
|
145
Teladoc Health
TDOC
$1.58B
| $32.6M | 0.14% |
257,376
+26,308
| +11% | +$3.83M |
|
146
Glaukos
GKOS
$9.02B
| $32.4M | 0.13% |
672,763
+668,934
| +17,470% | +$37.1M |
|
147
Wells Fargo
WFC
$261B
| $32.4M | 0.13% |
697,465
-227,471
| -25% | -$10.5M |
|
148
Prudential Financial
PRU
$41.7B
| $32.3M | 0.13% |
306,580
+64,941
| +27% | +$6.69M |
|
149
Brookfield
BN
$102B
| $32.1M | 0.13% |
1,111,127
+1,101,029
| +10,903% | +$32.1M |
|
|
150
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
| $32M | 0.13% |
634,900
+188,900
| +42% | +$9.83M |
|
Similar funds
Marshall Wace's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.
- Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
- Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
- Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
- Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
- Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
- Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
- Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.
Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.